What is it about?

We tested the efficacy of a novel carnosine derivative in an experimental mouse model of diabetic nephropathy. Results showed that this compund was able to prevent onset and stop progression of this serious complication of diabetes.

Featured Image

Read the Original

This page is a summary of: FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy indb/dbmice, British Journal of Pharmacology, December 2017, Wiley,
DOI: 10.1111/bph.14070.
You can read the full text:

Read

Contributors

The following have contributed to this page